Receipt of Establishment Inspection Report (EIR) by the Company from the U.S. FDA for its injectables facility in Nagpur India.
Lupin: Announcement under Regulation 30 (LODR)-Press Release / Media Release
December 16, 2025
Download PDF
Lupin